Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial
Moshe Mittelman*, Uwe Platzbecker, Boris Afanasyev, Sebastian Grosicki, Raymond S.M. Wong, Achilles Anagnostopoulos, Benjamin Brenner, Claudio Denzlinger, Giuseppe Rossi, Arnon Nagler, Regina Garcia-Delgado, Maria Socorro O. Portella, Zewen Zhu, Dominik Selleslag
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.